The 17 analysts offering 12-month price forecasts for Sanofi SA have a median target of 55.54, with a high estimate of 67.44 and a low estimate of 43.76. The median estimate represents a +18.85% increase from the last price of 46.73.
The current consensus among 21 polled investment analysts is to Buy stock in Sanofi SA. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.95
Reporting Date Feb 01
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.